Arkolith/Insider Trading/PALI/Form 4

Finley John David

CEO, CFO, DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$303K
Net Open-Market Flow
-$303K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)147K$2.07$303K218K
Jul 7, 2026Option exercise(M)133$0.70$93218K
Jul 6, 2026Option exercise(M)335K——364K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)133—$00
Jul 6, 2026Option exercise(M)335K—$01.7M

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-032559) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PALISADE BIO, INC.

Build

Ask your agent about PALI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-26-032559"
Ask your agent
Use Arkolith to summarize insider buying and selling at PALISADE BIO, INC.
over the last 90 days and cite the filings.